Aarti Drugs Share Price

Aarti Drugs Share Price

NSE: AARTIDRUGS
|
Pharmaceuticals
|
S Cap
₹ 437.20
+₹11.45 (2.69%)
1D
Last updated 23 Sep, 2026, 15:29 IST

Aarti Drugs Share Price Today

As of 23 Sep 2026, Aarti Drugs share price is ₹437.20. The stock opened at ₹428.95, compared to its previous close of ₹425.75. During today's trading session, Aarti Drugs share price moved in the range of ₹428.00 to ₹443.50, with an average price of ₹435.75 for the day. Looking at its last 52-week, the stock has touched a low of ₹318.95 and a high of ₹534.00. On the performance front, Aarti Drugs share price has increased by 24.07% over the last six months and is down 18.16% on a year-on-year basis.

₹428.00
2.69% up today
₹443.50
1D LOW
1D HIGH

Aarti Drugs Returns Calculator

Circuit
L
H
₹340.60
₹510.90
52-week
L
H
₹318.95
₹534.00

About Aarti Drugs

Aarti Drugs Share Price
ISIN
INE767A01016
Sector Market Cap
₹ 3,888.10 Cr

Aarti Drugs Limited is an India-based company, which is engaged in the manufacturing of active pharmaceutical ingredients (APIs), pharma intermediates, specialty chemicals and formulations. The Company operates in the pharmaceuticals segment. Its geographical segments include Out of India and India. The Company's APIs products include iprofloxacin hydrochloride, metronidazole, metformin HCL, ketoconazole, ofloxacin, and others. Its specialty chemicals include benzene sulphonyl chloride, methyl nicotinate, among others. Its pharma intermediates products include tinidazole, celecoxib, ciprofloxacin, clopidogrel, diclofenac, ketoconazole, raloxifene and zolpidem. Its products under development include alpha lipoic acid, itraconazole, ticagrelor, and sitagliptin. The Company's subsidiaries include Pinnacle Life Science Private Limited, Aarti Speciality Chemicals Limited, and Pinnacle Chile SPA.

Aarti Drugs Financial Highlights

  • Revenue: Aarti Drugs reported revenue of ₹2,567.70 crore in FY26 vs ₹2,403.39 crore in FY25. It showed an increase of 6.84% on a yearly basis.
  • Operating Profit: Aarti Drugs reported an operating profit of ₹210.90 crore in FY26 vs ₹211.77 crore in FY25. It showed a decrease of 0.41% on a year-on-year basis.
  • Net Profit: Aarti Drugs reported a net profit of ₹194.94 crore in FY26 vs ₹168.10 crore in FY25. It showed an increase of 15.97% on a yearly basis.

Aarti Drugs Quarterly Result Highlights

  • Aarti Drugs reported revenue of ₹703.59 crore in Jun 2026, compared with ₹721.06 crore in Mar 2026, representing a decrease of 2.42% on a quarter-on-quarter (QoQ) basis.
  • Aarti Drugs reported an operating profit of ₹69.24 crore in Jun 2026, compared with ₹70.36 crore in Mar 2026, representing a decrease of 1.59% on a quarter-on-quarter (QoQ) basis.
  • Aarti Drugs reported a profit of ₹50.13 crore in Jun 2026, compared with ₹55.26 crore in Mar 2026, reflecting a decrease of 9.28% on a QoQ basis.
  • The earnings per share (EPS) of Aarti Drugs stood at ₹21.36 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Know more
Promoters
54.43%
FII
1.52%
Other DII
0.21%
Retail and other
33.75%
Mutual funds
10.08%
Foreign Institutional Investor (FII)
FII shareholding by period
Sep 20252.69%
Dec 20252.15%
Mar 20261.58%
Jun 20261.52%
Mkt Cap Cr
3,888.10
P/E
20.34
P/B
2.51
ROE
12.58%
D/E
0.30
ROCE
11.51%
Div. Yield
0.47%
EPS(TTM)
18.54
Turnover
0.99
EV/EBITDA
13.60
Net Margin
7.49%
Op. Margin
11.73%
ROA
6.79%
Quick Ratio
1.13
Curr. Ratio
2.56
Based on fundamentals, this stock's
Step 5 of 5
Performance
Excellent
Aarti Drugs outperforming all market indices
Step 1 of 5
Valuation
Overvalued
Aarti Drugs appears overvalued compared to its peers
Step 3 of 5
Earnings
Neutral
Aarti Drugs earnings growth is positive
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,42,437.0036.515.2913.74%0.6117.33%93.240.87%0.4810.90
Divis Laboratories2,48,054.0084.8114.8015.32%0.0019.56%629.490.32%0.5598.19
Torrent Pharmaceuticals1,89,842.0088.0622.5725.49%1.6913.85%222.760.68%0.4958.70
Zydus Lifesciences1,15,810.0025.224.2718.59%0.3117.35%237.300.09%0.3335.38
Cipla1,11,565.0033.253.2411.27%0.0014.95%423.360.94%0.4543.52
Laurus Labs1,08,338.0099.3620.4416.77%0.4016.14%97.200.10%0.6713.72
Mankind Pharma1,02,410.0049.536.2811.74%0.3413.13%396.980.04%0.4449.37
Dr. Reddy's Laboratories1,01,163.0031.782.6611.07%0.1812.54%377.950.66%0.4138.68
Aurobindo Pharma97,641.6026.312.589.25%0.1911.76%394.820.24%0.3841.58
Lupin96,950.0017.474.3223.76%0.0424.88%658.960.85%0.57129.18

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

Aarti Drugs Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹2,565.31₹2,387.03₹2,528.58₹2,716.05
Other Income₹2.39₹16.36₹4.03₹2.19
Total Revenue₹2,567.70₹2,403.39₹2,532.61₹2,718.25
Total Expenses₹2,356.80₹2,191.62₹2,297.08₹2,494.07
Profit Before Tax₹210.90₹211.77₹235.53₹224.18
Tax₹15.96₹43.67₹63.94₹57.82
Profit After Tax₹194.94₹168.10₹171.59₹166.36
EPS - Basic₹21.36₹18.35₹18.65₹17.97
EPS - Diluted₹21.36₹18.35₹18.65₹17.97

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹210.90₹211.77₹235.53₹224.18
Income before WC changes₹313.66₹296.11₹318.54₹309.33
Change in Assets-₹87.85₹47.31₹195.32-₹88.60
Change in Liabilities₹23.63-₹43.73-₹92.53-₹27.74
Change in WC-₹64.22₹3.59₹102.79-₹116.34
Cash flow from Operations₹253.54₹244.58₹358.92₹133.32
Cash flow from Investing-₹173.41-₹164.63-₹223.65-₹163.97
Cash flow from Financing-₹77.44-₹82.12-₹136.03₹16.54
Total Cash Flow₹2.69-₹2.17-₹0.76-₹14.11
Cash (Start of the year)₹4.58₹6.74₹7.50₹21.61
Cash (End of the year)₹7.27₹4.58₹6.74₹7.50

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹1,347.49₹1,236.32₹1,111.64₹929.05
Current Assets₹1,467.77₹1,338.35₹1,320.72₹1,492.35
Total Assets₹2,815.26₹2,574.68₹2,432.36₹2,421.40
Current Liabilities₹922.26₹836.97₹795.54₹932.98
Net Current Asset₹545.52₹501.39₹525.18₹559.37
Non-Current Liabilities₹343.78₹368.37₹354.86₹295.75
Equity Capital₹1,549.23₹1,369.34₹1,281.95₹1,192.67
Total Equity & Liabilities₹2,815.26₹2,574.68₹2,432.36₹2,421.40

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹2,260.39₹2,173.65₹2,266.91₹2,497.97
Other Income₹2.59₹13.57₹4.18₹2.23
Total Revenue₹2,262.98₹2,187.23₹2,271.09₹2,500.20
Total Expenses₹2,081.67₹1,988.47₹2,078.61₹2,295.39
Profit Before Tax₹181.31₹198.75₹192.48₹204.81
Tax₹12.08₹41.44₹50.60₹52.00
Profit After Tax₹169.22₹157.31₹141.88₹152.81
EPS - Basic₹18.54₹17.18₹15.43₹16.50
EPS - Diluted₹18.54₹17.18₹15.43₹16.50

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹181.31₹198.75₹192.48₹204.81
Income before WC changes₹266.33₹268.84₹270.17₹283.24
Change in Assets-₹47.09₹9.12₹168.24-₹76.31
Change in Liabilities₹24.91-₹5.92-₹50.08₹9.60
Change in WC-₹22.17₹3.19₹118.17-₹66.71
Cash flow from Operations₹254.14₹220.08₹337.10₹161.70
Cash flow from Investing-₹127.58-₹134.92-₹187.09-₹131.14
Cash flow from Financing-₹126.27-₹84.60-₹148.81-₹30.54
Total Cash Flow₹0.29₹0.56₹1.20₹0.03
Cash (Start of the year)₹3.28₹2.72₹1.52₹1.49
Cash (End of the year)₹3.57₹3.28₹2.72₹1.52

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹1,168.84₹1,092.23₹990.60₹845.96
Current Assets₹1,212.76₹1,180.56₹1,181.02₹1,349.53
Total Assets₹2,381.60₹2,272.79₹2,171.62₹2,195.50
Current Liabilities₹712.63₹705.79₹684.60₹847.39
Net Current Asset₹500.12₹474.77₹496.42₹502.14
Non-Current Liabilities₹264.18₹315.65₹311.81₹233.80
Equity Capital₹1,404.79₹1,251.35₹1,175.21₹1,114.30
Total Equity & Liabilities₹2,381.60₹2,272.79₹2,171.62₹2,195.50
* All values are in INR Crore
Qty
Bid
0
0
0
0
0
0
0
0
0
0
Ask
Qty
0
0
0
0
0
0
0
0
0
0
Bid Total: 0
Ask Total: 0
Buy orders: 0%
Sell orders: 0%
Bearish
2
Neutral
5
Bullish
1
Slightly Bearish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
51.57
Neutral
ATR (14)
15.64
Neutral
STOCH(9,6)
44.7
Neutral
STOCH RSI (14)
1.2
Bullish
ADX(9)
22.67
Bearish
UO(9)
38.4
Neutral
ROC(12)
-0.02
Bearish
WillR(14)
-55.3
Neutral
Period
Simple value
Exponential vaue
5D
429.14
429.21
10D
428.25
428.09
20D
424.81
425.39
50D
419.73
416.51
100D
399.87
404.35
Volume trend — traded volume by day
23 Sep1L
22 Sep1L
21 Sep1L
18 Sep0L
17 Sep1L
16 Sep1L
Average1L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
Aarti Drugs Share Price
Aarti Drugs
Pharmaceuticals
Add Stock
Add Another

Aarti Drugs Share Price FAQs

Aarti Drugs share price data is sourced from NSE/BSE and may be delayed. It is displayed for informational purposes only and does not constitute investment advice or a recommendation to buy or sell.

Trusted by 2 Crore+ Indians for their wealth-building needs. SEBI Registered Broker. SEBI Reg No. INZ000315837